PET molecular imaging for pathophysiological visualization in Alzheimer’s disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PET molecular imaging for pathophysiological visualization in Alzheimer’s disease
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 50, Issue 3, Pages 765-783
Publisher
Springer Science and Business Media LLC
Online
2022-11-14
DOI
10.1007/s00259-022-05999-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- International consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer’s disease
- (2022) Mei Tian et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The PET tracer [ 11 C]MK-6884 quantifies M4 muscarinic receptor in rhesus monkeys and patients with Alzheimer’s disease
- (2022) Wenping Li et al. Science Translational Medicine
- 18F-FDG PET Imaging in Neurodegenerative Dementing Disorders: Insights into Subtype Classification, Emerging Disease Categories, and Mixed Dementia with Copathologies
- (2022) Satoshi Minoshima et al. JOURNAL OF NUCLEAR MEDICINE
- Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials
- (2022) Rik Ossenkoppele et al. LANCET NEUROLOGY
- Quantitative analysis of regional distribution of tau pathology with 11C-PBB3-PET in a clinical setting
- (2022) Elham Yousefzadeh-Nowshahr et al. PLoS One
- Novel 18F-Labeled Isonicotinamide-Based Radioligands for Positron Emission Tomography Imaging of Glycogen Synthase Kinase-3β
- (2021) Yuhua Zhong et al. MOLECULAR PHARMACEUTICS
- Transpathology: molecular imaging-based pathology
- (2021) Mei Tian et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Likely Common Role of Hypoxia in Driving 18F-FDG Uptake in Cancer, Myocardial Ischemia, Inflammation and Infection
- (2021) Yong Yao et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Differential expression of tau species and the association with cognitive decline and synaptic loss in Alzheimer's disease
- (2021) Sivaprakasam R. Saroja et al. Alzheimers & Dementia
- Ruthenium-Mediated 18F-Fluorination and Preclinical Evaluation of a New CB1 Receptor Imaging Agent [18F]FPATPP
- (2020) Salla Lahdenpohja et al. ACS Chemical Neuroscience
- GSK3‐ARC/Arg3.1 and GSK3‐Wnt signaling axes trigger amyloid‐β accumulation and neuroinflammation in middle‐aged Shugoshin 1 mice
- (2020) Chinthalapally V. Rao et al. AGING CELL
- High availability of the α7 nicotinic acetylcholine receptor in brains of individuals with mild cognitive impairment: A pilot study using 18F-ASEM PET
- (2019) Jennifer M. Coughlin et al. JOURNAL OF NUCLEAR MEDICINE
- The neurochemistry of agitation in Alzheimer’s disease: a systematic review
- (2018) Kathy Y. Liu et al. AGEING RESEARCH REVIEWS
- Distinct [18F]THK5351 binding patterns in primary progressive aphasia variants
- (2018) Jolien Schaeverbeke et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Kinetic modeling of [18 F]VAT, a novel radioligand for positron emission tomography imaging vesicular acetylcholine transporter in non-human primate brain
- (2018) Hongjun Jin et al. JOURNAL OF NEUROCHEMISTRY
- First-in-human brain imaging of Alzheimer dementia patients and elderly controls with18F-MK-6240, a PET tracer targeting neurofibrillary tangle pathology
- (2018) Talakad G Lohith et al. JOURNAL OF NUCLEAR MEDICINE
- First in-human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948
- (2018) Dean F. Wong et al. JOURNAL OF NUCLEAR MEDICINE
- Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer’s Disease
- (2018) Malin Olsen et al. MOLECULAR IMAGING AND BIOLOGY
- [ 18 F]FMPEP- d 2 PET imaging shows age- and genotype-dependent impairments in the availability of cannabinoid receptor 1 in a mouse model of Alzheimer's disease
- (2018) Jatta S. Takkinen et al. NEUROBIOLOGY OF AGING
- Efficient clearance of Aβ protofibrils in AβPP-transgenic mice treated with a brain-penetrating bifunctional antibody
- (2018) Stina Syvänen et al. Alzheimers Research & Therapy
- Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort
- (2018) Arno de Wilde et al. JAMA Neurology
- Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia
- (2018) Willemijn J. Jansen et al. JAMA Psychiatry
- FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort
- (2018) Silvia Paola Caminiti et al. NeuroImage-Clinical
- Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [18F]FDG PET
- (2018) Sabine Hellwig et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Specific Uptake of an Amyloid-β Protofibril-Binding Antibody-Tracer in AβPP Transgenic Mouse Brain
- (2018) Kristina Magnusson et al. JOURNAL OF ALZHEIMERS DISEASE
- Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807
- (2018) David T. Chien et al. JOURNAL OF ALZHEIMERS DISEASE
- Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F18]-T808
- (2018) David T. Chien et al. JOURNAL OF ALZHEIMERS DISEASE
- The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer's Disease
- (2018) Gaurav Bedse et al. JOURNAL OF ALZHEIMERS DISEASE
- Positron Emission Tomography (PET) Ligand Development for Ionotropic Glutamate Receptors: Challenges and Opportunities for Radiotracer Targeting N-Methyl-d-aspartate (NMDA), α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA), and Kainate Receptors
- (2018) Hualong Fu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease
- (2018) Andrew J. Aschenbrenner et al. NEUROLOGY
- Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology
- (2018) Renaud La Joie et al. Alzheimers & Dementia
- High detection sensitivity with antibody-based PET radioligand for amyloid beta in brain
- (2018) Xiaotian T. Fang et al. NEUROIMAGE
- Autophagy induces G0/G1 arrest and apoptosis in menstrual blood-derived endometrial stem cells via GSK3-β/β-catenin pathway
- (2018) Jiang Du et al. Stem Cell Research & Therapy
- Involvement of the Precuneus/Posterior Cingulate Cortex Is Significant for the Development of Alzheimer’s Disease: A PET (THK5351, PiB) and Resting fMRI Study
- (2018) Takamasa Yokoi et al. Frontiers in Aging Neuroscience
- 18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage
- (2017) Silvia Morbelli et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Head to head comparison of [18F] AV-1451 and [18F] THK5351 for tau imaging in Alzheimer’s disease and frontotemporal dementia
- (2017) Young Kyoung Jang et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer’s Disease in a Clinical Setting
- (2017) Leonardo Iaccarino et al. JOURNAL OF ALZHEIMERS DISEASE
- Perspectives of Cannabinoid Type 2 Receptor (CB2R) Ligands in Neurodegenerative Disorders: Structure–Affinity Relationship (SAfiR) and Structure–Activity Relationship (SAR) Studies
- (2017) Francesco Spinelli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity
- (2017) Sudeepti Southekal et al. JOURNAL OF NUCLEAR MEDICINE
- Test–Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18
- (2017) Michael D. Devous et al. JOURNAL OF NUCLEAR MEDICINE
- Tau positron emission tomography using [ 18 F]THK5351 and cerebral glucose hypometabolism in Alzheimer's disease
- (2017) Jae Myeong Kang et al. NEUROBIOLOGY OF AGING
- Synthesis, resolution, and in vitro evaluation of three vesicular acetylcholine transporter ligands and evaluation of the lead fluorine-18 radioligand in a nonhuman primate
- (2017) Xuyi Yue et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Metabotropic glutamate receptors and neurodegenerative diseases
- (2017) Fabiola M. Ribeiro et al. PHARMACOLOGICAL RESEARCH
- Development of [18F]Maleimide-Based Glycogen Synthase Kinase-3β Ligands for Positron Emission Tomography Imaging
- (2017) Kongzhen Hu et al. ACS Medicinal Chemistry Letters
- Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database
- (2017) Fayçal Ben Bouallègue et al. Alzheimers Research & Therapy
- Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain
- (2017) Kok Pin Ng et al. Alzheimers Research & Therapy
- Regional correlations between [ 11 C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort
- (2017) Sang Won Seo et al. NeuroImage-Clinical
- Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson’s case
- (2017) Marta Marquié et al. Acta Neuropathologica Communications
- Drug Development Based on the Metals Hypothesis of Alzheimer's Disease
- (2017) Ashley I. Bush JOURNAL OF ALZHEIMERS DISEASE
- Brain fluorodeoxyglucose (FDG) PET in dementia
- (2016) Takashi Kato et al. AGEING RESEARCH REVIEWS
- Amyloid imaging: Past, present and future perspectives
- (2016) Victor L. Villemagne AGEING RESEARCH REVIEWS
- Trends in dementia incidence: Evolution over a 10-year period in France
- (2016) Leslie Grasset et al. Alzheimers & Dementia
- Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease
- (2016) Andrei G. Vlassenko et al. ANNALS OF NEUROLOGY
- Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies
- (2016) Lidia Sarro et al. BRAIN
- Regional profiles of the candidate tau PET ligand18F-AV-1451 recapitulate key features of Braak histopathological stages
- (2016) Adam J. Schwarz et al. BRAIN
- Early and protective microglial activation in Alzheimer’s disease: a prospective study using18F-DPA-714 PET imaging
- (2016) Lorraine Hamelin et al. BRAIN
- Tau imaging with [18F]THK-5351 in progressive supranuclear palsy
- (2016) A. Ishiki et al. EUROPEAN JOURNAL OF NEUROLOGY
- Cholinergic imaging in dementia spectrum disorders
- (2016) Roman Roy et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers
- (2016) Lele Xu et al. JOURNAL OF ALZHEIMERS DISEASE
- Distribution and Load of Amyloid-β Pathology in Parkinson Disease and Dementia with Lewy Bodies
- (2016) Dagmar H. Hepp et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Kinetics of the Tau PET Tracer 18F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease
- (2016) S. Shcherbinin et al. JOURNAL OF NUCLEAR MEDICINE
- Dementia in western Europe: epidemiological evidence and implications for policy making
- (2016) Yu-Tzu Wu et al. LANCET NEUROLOGY
- Usefulness of 3-dimensional stereotactic surface projection FDG PET images for the diagnosis of dementia
- (2016) Jahae Kim et al. MEDICINE
- In vivo visualization of tau deposits in corticobasal syndrome by 18 F-THK5351 PET
- (2016) Akio Kikuchi et al. NEUROLOGY
- Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly
- (2016) Jasmeer P. Chhatwal et al. NEUROLOGY
- Agonist and antagonist bind differently to 5-HT 1A receptors during Alzheimer’s disease: A post-mortem study with PET radiopharmaceuticals
- (2016) Benjamin Vidal et al. NEUROPHARMACOLOGY
- A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates
- (2016) Stephan Hjorth et al. NEUROPHARMACOLOGY
- Incidence of Dementia over Three Decades in the Framingham Heart Study
- (2016) Claudia L. Satizabal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kinetics modeling and occupancy studies of a novel C-11 PET tracer for VAChT in nonhuman primates
- (2016) Hongjun Jin et al. NUCLEAR MEDICINE AND BIOLOGY
- A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II
- (2016) F. E. Matthews et al. Nature Communications
- Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging
- (2016) Mukesh K. Pandey et al. Theranostics
- An autoradiographic evaluation of AV-1451 Tau PET in dementia
- (2016) Val J. Lowe et al. Acta Neuropathologica Communications
- Use of Standardized Uptake Value Ratios Decreases Interreader Variability of [18F] Florbetapir PET Brain Scan Interpretation
- (2015) A. P. Nayate et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Tau positron emission tomographic imaging in aging and early Alzheimer disease
- (2015) Keith A. Johnson et al. ANNALS OF NEUROLOGY
- Is amyloid-β harmful to the brain? Insights from human imaging studies
- (2015) William Jagust BRAIN
- Amyloid β Accumulation Assessed with 11C-Pittsburgh Compound B PET and Postmortem Neuropathology
- (2015) Hiroyuki Hatsuta et al. Current Alzheimer Research
- Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting
- (2015) Daniela Perani et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Diagnostic accuracy of 18F amyloid PET tracers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis
- (2015) Elizabeth Morris et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Tau imaging in neurodegenerative diseases
- (2015) M. Dani et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Default-mode network functional connectivity is closely related to metabolic activity
- (2015) Susanne Passow et al. HUMAN BRAIN MAPPING
- Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study
- (2015) H. Shimada et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- PET Quantification of Tau Pathology in Human Brain with 11C-PBB3
- (2015) Y. Kimura et al. JOURNAL OF NUCLEAR MEDICINE
- 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
- (2015) R. Harada et al. JOURNAL OF NUCLEAR MEDICINE
- The case for rejecting the amyloid cascade hypothesis
- (2015) Karl Herrup NATURE NEUROSCIENCE
- Clearance systems in the brain—implications for Alzheimer disease
- (2015) Jenna M. Tarasoff-Conway et al. Nature Reviews Neurology
- Tau in physiology and pathology
- (2015) Yipeng Wang et al. NATURE REVIEWS NEUROSCIENCE
- Amyloid-β11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
- (2015) Enchi Liu et al. NEUROLOGY
- Development of PET and SPECT Probes for Glutamate Receptors
- (2015) Takeshi Fuchigami et al. TheScientificWorldJOURNAL
- Amyloid biomarkers in Alzheimer's disease
- (2015) Kaj Blennow et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Glutamate receptors function as scaffolds for the regulation of β-amyloid and cellular prion protein signaling complexes
- (2015) Alison Hamilton et al. Molecular Brain
- Development of PET and SPECT Probes for Glutamate Receptors
- (2015) Takeshi Fuchigami et al. Scientific World Journal
- The axonal cytoskeleton: from organization to function
- (2015) Josta T. Kevenaar et al. Frontiers in Molecular Neuroscience
- Loss of tau rescues inflammation-mediated neurodegeneration
- (2015) Nicole Maphis et al. Frontiers in Neuroscience
- Comparison of qualitative and quantitative imaging characteristics of [ 11 C]PiB and [ 18 F]flutemetamol in normal control and Alzheimer's subjects
- (2015) James M. Mountz et al. NeuroImage-Clinical
- Endocannabinoid signalling in Alzheimer's disease
- (2015) Nazia Maroof et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Predicting Alzheimer disease with β-amyloid imaging: Results from the Australian imaging, biomarkers, and lifestyle study of ageing
- (2014) Christopher C. Rowe et al. ANNALS OF NEUROLOGY
- Time for tau
- (2014) William Jagust BRAIN
- PET/SPECT imaging agents for neurodegenerative diseases
- (2014) Lin Zhu et al. CHEMICAL SOCIETY REVIEWS
- Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers
- (2014) S. M. Landau et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18 F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy
- (2014) Amane Tateno et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Tracking neuroinflammation in Alzheimer’s disease: the role of positron emission tomography imaging
- (2014) Eduardo Zimmer et al. Journal of Neuroinflammation
- Radiosynthesis, Photoisomerization, Biodistribution, and Metabolite Analysis of 11C-PBB3 as a Clinically Useful PET Probe for Imaging of Tau Pathology
- (2014) H. Hashimoto et al. JOURNAL OF NUCLEAR MEDICINE
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Antiamyloid Therapy for Alzheimer's Disease — Are We on the Right Road?
- (2014) Eric Karran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting Metal-Aβ Aggregates with Bifunctional Radioligand [11C]L2-b and a Fluorine-18 Analogue [18F]FL2-b
- (2014) Brian P. Cary et al. ACS Medicinal Chemistry Letters
- Assessing THK523 selectivity for tau deposits in Alzheimer’s disease and non–Alzheimer’s disease tauopathies
- (2014) Michelle T Fodero-Tavoletti et al. Alzheimers Research & Therapy
- Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting
- (2014) Daniela Perani et al. NeuroImage-Clinical
- Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease
- (2014) Niklas Mattsson et al. Annals of Clinical and Translational Neurology
- The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy
- (2013) Patrick L. McGeer et al. ACTA NEUROPATHOLOGICA
- Glucose dependence of glycogen synthase activity regulation by GSK3 and MEK/ERK inhibitors and angiotensin-(1–7) action on these pathways in cultured human myotubes
- (2013) Marta Montori-Grau et al. CELLULAR SIGNALLING
- In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer’s disease patients
- (2013) Andrea Varrone et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Neuropathologic Heterogeneity Does Not Impair Florbetapir-Positron Emission Tomography Postmortem Correlates
- (2013) Brittany N. Dugger et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Head-to-Head Comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for -Amyloid Imaging in Aging and Dementia
- (2013) C. C. Rowe et al. JOURNAL OF NUCLEAR MEDICINE
- Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease
- (2013) N. Okamura et al. JOURNAL OF NUCLEAR MEDICINE
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
- (2013) Masahiro Maruyama et al. NEURON
- Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease
- (2013) T. L. S. Benzinger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of MK-3168: A PET Tracer for Imaging Brain Fatty Acid Amide Hydrolase
- (2013) Ping Liu et al. ACS Medicinal Chemistry Letters
- Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls
- (2012) Thomas J. Esparza et al. ANNALS OF NEUROLOGY
- In vivo assessment of amyloid-β deposition in nondemented very elderly subjects
- (2012) Chester A. Mathis et al. ANNALS OF NEUROLOGY
- The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
- (2012) I. W. Hamley CHEMICAL REVIEWS
- Selectively Silencing GSK-3 Isoforms Reduces Plaques and Tangles in Mouse Models of Alzheimer's Disease
- (2012) D. E. Hurtado et al. JOURNAL OF NEUROSCIENCE
- Clinical Validation of 18F-AZD4694, an Amyloid- -Specific PET Radioligand
- (2012) Z. Cselenyi et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical Alzheimer disease—the challenges ahead
- (2012) Reisa A. Sperling et al. Nature Reviews Neurology
- Amyloid deposition detected with florbetapir F 18 (18F-AV-45) is related to lower episodic memory performance in clinically normal older individuals
- (2012) Reisa A. Sperling et al. NEUROBIOLOGY OF AGING
- Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment–dementia converters measured by positron emission tomography with [11C]DAA1106
- (2012) Fumihiko Yasuno et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Predicting Cognitive Decline in Subjects at Risk for Alzheimer Disease by Using Combined Cerebrospinal Fluid, MR Imaging, and PET Biomarkers
- (2012) Jennifer L. Shaffer et al. RADIOLOGY
- Synthesis and PET imaging studies of [18F]2-fluoroquinolin-8-ol ([18F]CABS13) in transgenic mouse models of Alzheimer's disease
- (2012) Neil Vasdev et al. MedChemComm
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
- (2011) Victor L. Villemagne et al. ANNALS OF NEUROLOGY
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- New Tools for the Study of Alzheimer’s Disease
- (2011) Anders M. Fjell et al. NEUROSCIENTIST
- The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core
- (2010) William J. Jagust et al. Alzheimers & Dementia
- Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand
- (2010) Anders Juréus et al. JOURNAL OF NEUROCHEMISTRY
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum
- (2010) David M. Lovinger NEUROPHARMACOLOGY
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- [11C]CURB: Evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography
- (2010) Alan A. Wilson et al. NUCLEAR MEDICINE AND BIOLOGY
- Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease
- (2009) N. Nelissen et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical Properties of 18F-AV-45: A PET Agent for A Plaques in the Brain
- (2009) S. R. Choi et al. JOURNAL OF NUCLEAR MEDICINE
- Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study
- (2009) A. Okello et al. NEUROLOGY
- Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia
- (2009) Reisa A. Sperling et al. NEURON
- Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
- (2009) Diane P. Hanger et al. TRENDS IN MOLECULAR MEDICINE
- Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
- (2008) Milos D. Ikonomovic et al. BRAIN
- Imaging Neuroinflammation in Alzheimer's Disease with Radiolabeled Arachidonic Acid and PET
- (2008) G. Esposito et al. JOURNAL OF NUCLEAR MEDICINE
- Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias
- (2008) L. Mosconi et al. JOURNAL OF NUCLEAR MEDICINE
- Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism
- (2008) Christopher C Rowe et al. LANCET NEUROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started